Clinical Trial Update: Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

View source ↗

Summary

This clinical trial update summarizes post-approval surveillance data on the use of sofosbuvir plus ribavirin in Japanese patients with chronic hepatitis C infe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Status: COMPLETED